Prevalence of Elevated High Sensitive Cardiac Troponin-T in Individuals with a Negative Stress test

אסי מילביצקי Department of Cardiology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Israel Eyal Fisher Department of Statistics, School of Mathematical Science, Tel Aviv University, Tel Aviv, Israel., Israel Michal Ehrenwald Departments of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Israel Gabi Shefer Institute of Endocrinology, Metabolism and Hypertension,, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv Israel., Israel Naftali Stern Institute of Endocrinology, Metabolism and Hypertension,, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv Israel., Israel Itzhak Shapira Departments of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Israel David Zeltser Departments of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Israel Shlomo Berliner Departments of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Israel Shani Shenhar-Tsarfaty Departments of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Israel Ori Rogowski Departments of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Israel Rafael Brzezinski Departments of Internal Medicine “C”, “D” and “E”, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Israel

Background: The exercise ECG stress test (EST) is still the first step of work-up in intermediate risk patients in many clinical scenarios. High sensitive cardiac troponin T (hs-cTnT) elevation is related to future cardiovascular events in the general population and in patients with ischemic heart disease. The relation between these two tests is not well described.

Methods: A total of 2,783 participants from the Tel-Aviv Medical Center Inflammation Survey cohort (mean age 49 years, 79% men) were analyzed. Multiple physiologic and metabolic parameters including high sensitive cardiac troponin T were collected. All participants completed an EST manually reviewed on the spot by a cardiologist.

Results: A Positive EST was documented in 224 subjects (8%). Cardiac troponin T concentrations were not significantly different between individuals with a negative and positive EST, 5.7 (4.1-7.8) vs. 6.2 (4.8-9.1) ng/L for median (IQR) respectively, p=0.07. The majority (91%) of participants with high sensitive cardiac troponin T levels of 5-13.9 ng/L had a negative EST as well as 89.3% of subjects with levels > 14 ng/L. The proportion of subjects with a positive EST and detectable hs-cTnT levels was non significantly greater compared to those with a negative EST (53.1% vs. 46.2% respectively, p=0.09).

Conclusion: Among subjects referred for EST as part of an annual health survey we found no significant association between EST results to hs-cTnT elevation.

Click the link to view image: https://events.eventact.com/dan/29113/102731.jpg
אסי מילביצקי
אסי מילביצקי
TEL-AVIV MEDICAL CENTER








Powered by Eventact EMS